NUVALOP-ER 500 TABLETS

Product Details :

Feature	Details
Product Name	NUVALOP-ER 500 Tablets
Form	Extended-Release Tablets
Key Ingredients	Sodium Valproate 333 mg + Valproic Acid 145 mg
Total Strength	500 mg (as extended-release formulation)
Core Benefits	Controls seizures, stabilizes mood, prevents migraines
Support Areas	Epilepsy, bipolar disorder, migraine prophylaxis
Recommended Usage	As prescribed by a neurologist or psychiatrist
Target Audience	Patients with epilepsy, mood disorders, or chronic migraine
Packaging Type	Blister pack
Available Pack Sizes	10x1x10 tablets

Composition: Divalproex Sodium Extended Release 500mg Packing: 10×10 Alu-Alu Description : NUVALOP-ER 500 Tablets contain Sodium Valproate 333 mg and Valproic Acid 145 mg (total 500 mg), used for the effective management of epilepsy, bipolar disorder, and migraine prophylaxis. As an extended-release (ER) formulation, it ensures steady drug levels in the bloodstream, offering consistent seizure control and mood stabilization. NUVALOP-ER 500 is ideal for patients needing long-term therapy, reducing seizure frequency and intensity while improving quality of life. It is generally well-tolerated under proper medical supervision.